1 |
NAMES OF REPORTING PERSONS
|
|
|
||
Bank of America Corporation 56-0906609
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☒
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☒ | ||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
0
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
0%
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
HC
|
|
|
|||
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Banc of America Preferred Funding Corporation 75-2939570
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☒
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
0
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
0%
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
co
|
|
|
|||
|
|
Item 1. |
Security and Issuer
|
Item 2. |
Identity and Background
|
Item 5. |
Interest in Securities of the Issuer
|
Item 7. |
Material to be Filed as Exhibits
|
"Exhibit | Description of Exhibit |
Joint Filing Agreement, dated as of December 13, 2024, by and among the Reporting Persons.
|
|
Power of Attorney, relating to each of the Reporting Persons.
|
BANK OF AMERICA CORPORATION
|
||
By:
|
/s/ Andres Ortiz
|
|
Name: Andres Ortiz
|
||
Title: Authorized Signatory
|
BANC OF AMERICA PREFERRED FUNDING
CORPORATION
|
||
By:
|
/s/ Andres Ortiz | |
Name: Andres Ortiz
|
||
Title: Authorized Signatory
|
Name
|
Position with Bank of
America Corporation
|
Principal Occupation
|
||
Brian T. Moynihan
|
Chairman of the Board, Chief Executive Officer and Director
|
Chairman of the Board and Chief Executive Officer of Bank of America Corporation
|
||
Paul M. Donofrio
|
Vice Chair
|
Vice Chair of Bank of America Corporation
|
||
Thong M. Nguyen
|
Vice Chair, Head of Global Strategy & Enterprise Platforms
|
Vice Chair, Head of Global Strategy & Enterprise Platforms of Bank of America Corporation
|
||
Bruce R. Thompson
|
Vice Chair, Head of Enterprise Credit
|
Vice Chair, Head of Enterprise Credit of Bank of America Corporation
|
||
Dean C. Athanasia
|
President, Regional Banking
|
President, Regional Banking of Bank of America Corporation
|
||
James P. DeMare
|
President, Global Markets
|
President, Global Markets of Bank of America Corporation
|
||
Kathleen A. Knox
|
President, The Private Bank
|
President, The Private Bank of Bank of America Corporation
|
||
Matthew M. Koder
|
President, Global Corporate and Investment Banking
|
President, Global Corporate and Investment Banking of Bank of America Corporation
|
||
Bernard A. Mensah
|
President, International; CEO, Merrill Lynch International
|
President, International of Bank of America Corporation and CEO, Merrill Lynch International
|
||
Lindsay DeNardo Hans
|
President, Co-Head Merrill Wealth Management
|
President, Co-Head Merrill Wealth Management of Bank of America Corporation
|
||
Eric Schimpf
|
President, Co-Head Merrill Wealth Management
|
President, Co-Head Merrill Wealth Management of Bank of America Corporation
|
||
Aditya Bhasin
|
Chief Technology and Information Officer
|
Chief Technology and Information Officer of Bank of America Corporation
|
||
D. Steve Boland
|
Chief Administrative Officer
|
Chief Administrative Officer of Bank of America Corporation
|
||
Alastair Borthwick
|
Chief Financial Officer
|
Chief Financial Officer of Bank of America Corporation
|
Sheri Bronstein
|
Chief Human Resources Officer
|
Chief Human Resources Officer of Bank of America Corporation
|
||
Geoffrey Greener
|
Chief Risk Officer
|
Chief Risk Officer of Bank of America Corporation
|
||
Thomas M. Scrivener
|
Chief Operations Executive
|
Chief Operations Executive of Bank of America Corporation
|
||
Lauren A. Mogensen
|
Global General Counsel
|
Global General Counsel of Bank of America Corporation
|
||
Lionel L. Nowell, III
|
Lead Independent Director
|
Lead Independent Director, Bank of America Corporation; Former Senior Vice President and Treasurer, PepsiCo, Inc.
|
||
Sharon L. Allen
|
Director
|
Former Chairman, Deloitte LLP
|
||
Jose E. Almeida
|
Director
|
Chairman, President and Chief Executive Officer of Baxter International Inc.
|
||
Pierre J.P. de Weck1
|
Director
|
Former Chairman and Global Head of Private Wealth Management, Deutsche Bank AG
|
||
Arnold W. Donald
|
Director
|
Former President and Chief Executive Officer, Carnival Corporation & Carnival plc
|
||
Linda P. Hudson
|
Director
|
Former Executive Officer, The Cardea Group, LLC and Former President and Chief Executive Officer of BAE Systems, Inc.
|
||
Monica C. Lozano
|
Director
|
Lead Independent Director, Target Corporation; Former Chief Executive Officer, Former College Futures Foundation and Former Chairman, US Hispanic Media Inc.
|
||
Denise L. Ramos
|
Director
|
Former Chief Executive Officer and President of ITT Inc.
|
||
Clayton S. Rose
|
Director
|
Baker Foundation Professor of Management Practice at Harvard Business School
|
||
Michael D. White
|
Director
|
Former Chairman, President, and Chief Executive Officer of DIRECTV
|
||
Thomas D. Woods2
|
Director
|
Former Vice Chairman and Senior Executive Vice President of Canadian Imperial Bank of Commerce; Former Chairman, Hydro One Limited
|
||
Maria T. Zuber
|
Director
|
Vice President for Research and E.A., Griswold Professor of Geophysics, MIT
|
Name
|
Position with Banc of
America Preferred Funding
Corporation
|
Principal Occupation
|
||
John J. Lawlor
|
Director and President
|
Managing Director, Municipal Markets and Public Sector Banking Executive of BofA Securities, Inc. and Bank of America, National Association
|
||
James Duffy
|
Managing Director
|
Director; MBAM BFO, The CFO Group of Bank of America, National Association
|
||
Michael I. Jentis
|
Managing Director
|
Managing Director, Head of Sales – Public Finance of BofA Securities, Inc. and Bank of America, National Association
|
||
Mona Payton
|
Managing Director
|
Managing Director, Municipal Markets Executive for Short-Term Trading of BofA Securities, Inc. and Bank of America, National Association
|
||
Edward J. Sisk
|
Director and Managing Director
|
Managing Director, Public Finance Executive of BofA Securities, Inc. and Bank of America, National Association
|
||
John B. Sprung
|
Director
|
Corporate Director
|
||
David A. Stephens
|
Director and Managing Director
|
Managing Director, Executive for Public Finance and Public Sector Credit Products of BofA Securities, Inc. and Bank of America, National Association
|
TRADE DATE
|
BUY/SELL |
QUANTITY
|
PRICE
|
EXECUTION
|
||||||||
08/19/2013
|
B
|
100
|
$
|
10.14
|
OTC
|
|||||||
08/19/2013
|
B
|
100
|
$
|
10.14
|
OTC
|
|||||||
08/19/2013
|
B
|
73
|
$
|
10.15
|
OTC
|
|||||||
08/19/2013
|
B
|
200
|
$
|
10.15
|
OTC
|
|||||||
08/19/2013
|
B
|
100
|
$
|
10.13
|
OTC
|
|||||||
08/19/2013
|
B
|
40
|
$
|
10.13
|
OTC
|
|||||||
08/19/2013
|
B
|
1,887
|
$
|
10.13
|
OTC
|
|||||||
08/19/2013
|
B
|
2,400
|
$
|
10.16
|
OTC
|
|||||||
08/19/2013
|
B
|
100
|
$
|
10.14
|
OTC
|
|||||||
08/19/2013
|
S
|
100
|
$
|
10.21
|
OTC
|
|||||||
08/19/2013
|
S
|
2,400
|
$
|
10.2
|
OTC
|
|||||||
08/19/2013
|
S
|
100
|
$
|
10.15
|
OTC
|
|||||||
08/19/2013
|
S
|
1,000
|
$
|
10.15
|
OTC
|
|||||||
08/19/2013
|
S
|
1,400
|
$
|
10.11
|
OTC
|
|||||||
08/20/2013
|
S
|
200
|
$
|
10.15
|
OTC
|
|||||||
08/20/2013
|
S
|
1,133
|
$
|
10.2165
|
OTC
|
|||||||
08/20/2013
|
S
|
1,200
|
$
|
10.1871
|
OTC
|
|||||||
08/22/2013
|
B
|
605
|
$
|
10.23
|
OTC
|
|||||||
08/22/2013
|
S
|
605
|
$
|
10.1839
|
OTC
|
|||||||
09/03/2013
|
B
|
2,460
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
B
|
4,000
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
B
|
1,000
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
B
|
100
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
B
|
3
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
B
|
3,500
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
B
|
37
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
B
|
500
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
B
|
1,900
|
$
|
10.24
|
OTC
|
|||||||
09/03/2013
|
S
|
500
|
$
|
10.06
|
OTC
|
|||||||
09/03/2013
|
S
|
1,200
|
$
|
10.06
|
OTC
|
|||||||
09/03/2013
|
S
|
300
|
$
|
10.07
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
10.04
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
10.03
|
OTC
|
|||||||
09/03/2013
|
S
|
250
|
$
|
10.03
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
10.02
|
OTC
|
|||||||
09/03/2013
|
S
|
1,000
|
$
|
9.99
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
10.02
|
OTC
|
|||||||
09/03/2013
|
S
|
1,900
|
$
|
9.96
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
9.97
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
9.99
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
9.97
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
10.0
|
OTC
|
|||||||
09/03/2013
|
S
|
500
|
$
|
9.91
|
OTC
|
|||||||
09/03/2013
|
S
|
110
|
$
|
9.91
|
OTC
|
|||||||
09/03/2013
|
S
|
300
|
$
|
9.91
|
OTC
|
|||||||
09/03/2013
|
S
|
22
|
$
|
9.95
|
OTC
|
|||||||
09/03/2013
|
S
|
18
|
$
|
9.88
|
OTC
|
|||||||
09/03/2013
|
S
|
400
|
$
|
9.88
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
9.89
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
9.88
|
OTC
|
|||||||
09/03/2013
|
S
|
500
|
$
|
9.88
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
9.92
|
OTC
|
|||||||
09/03/2013
|
S
|
482
|
$
|
9.88
|
OTC
|
|||||||
09/03/2013
|
S
|
300
|
$
|
9.86
|
OTC
|
|||||||
09/03/2013
|
S
|
100
|
$
|
9.87
|
OTC
|
|||||||
09/03/2013
|
S
|
4,118
|
$
|
9.85
|
OTC
|
|||||||
09/03/2013
|
S
|
400
|
$
|
9.88
|
OTC
|
|||||||
10/17/2013
|
B
|
100
|
$
|
10.1
|
OTC
|
|||||||
10/17/2013
|
B
|
100
|
$
|
10.1
|
OTC
|
|||||||
10/17/2013
|
B
|
100
|
$
|
10.1
|
OTC
|
|||||||
10/17/2013
|
B
|
100
|
$
|
10.1
|
OTC
|
|||||||
10/17/2013
|
S
|
400
|
$
|
10.1201
|
OTC
|
|||||||
10/24/2013
|
B
|
5,000
|
$
|
10.66
|
OTC
|
|||||||
10/29/2013
|
S
|
570
|
$
|
10.5
|
OTC
|
|||||||
10/29/2013
|
S
|
1,900
|
$
|
10.51
|
OTC
|
|||||||
10/29/2013
|
S
|
30
|
$
|
10.51
|
OTC
|
|||||||
10/29/2013
|
S
|
500
|
$
|
10.52
|
OTC
|
|||||||
10/29/2013
|
S
|
100
|
$
|
10.51
|
OTC
|
|||||||
10/29/2013
|
S
|
1,000
|
$
|
10.5
|
OTC
|
|||||||
10/29/2013
|
S
|
900
|
$
|
10.5
|
OTC
|
|||||||
12/18/2013
|
B
|
300
|
$
|
10.34
|
OTC
|
|||||||
12/18/2013
|
B
|
100
|
$
|
10.34
|
OTC
|
|||||||
12/18/2013
|
B
|
700
|
$
|
10.33
|
OTC
|
|||||||
12/18/2013
|
B
|
600
|
$
|
10.335
|
OTC
|
|||||||
12/18/2013
|
S
|
200
|
$
|
10.32
|
OTC
|
|||||||
12/18/2013
|
S
|
1,300
|
$
|
10.3201
|
OTC
|
|||||||
12/18/2013
|
S
|
100
|
$
|
10.32
|
OTC
|
|||||||
12/18/2013
|
S
|
100
|
$
|
10.32
|
OTC
|
|||||||
12/26/2013
|
B
|
800
|
$
|
10.325
|
OTC
|
|||||||
12/26/2013
|
S
|
800
|
$
|
10.3201
|
OTC
|
|||||||
12/27/2013
|
S
|
350
|
$
|
10.3593
|
OTC
|
|||||||
12/31/2013
|
B
|
350
|
$
|
10.23
|
OTC
|
|||||||
01/17/2014
|
S
|
119
|
$
|
10.82
|
OTC
|
|||||||
01/17/2014
|
S
|
955
|
$
|
10.82
|
OTC
|
|||||||
01/17/2014
|
S
|
300
|
$
|
10.8
|
OTC
|
|||||||
01/17/2014
|
S
|
100
|
$
|
10.8
|
OTC
|
|||||||
01/17/2014
|
S
|
100
|
$
|
10.82
|
OTC
|
|||||||
01/17/2014
|
S
|
200
|
$
|
10.8
|
OTC
|
|||||||
01/17/2014
|
S
|
200
|
$
|
10.8
|
OTC
|
|||||||
01/17/2014
|
S
|
100
|
$
|
10.8
|
OTC
|
|||||||
01/17/2014
|
S
|
500
|
$
|
10.8
|
OTC
|
|||||||
01/17/2014
|
S
|
426
|
$
|
10.79
|
OTC
|
|||||||
01/17/2014
|
S
|
100
|
$
|
10.79
|
OTC
|
|||||||
01/17/2014
|
S
|
100
|
$
|
10.77
|
OTC
|
|||||||
01/17/2014
|
S
|
900
|
$
|
10.77
|
OTC
|
|||||||
01/17/2014
|
S
|
274
|
$
|
10.79
|
OTC
|
|||||||
01/17/2014
|
S
|
100
|
$
|
10.8
|
OTC
|
|||||||
01/17/2014
|
S
|
526
|
$
|
10.77
|
OTC
|
|||||||
04/23/2014
|
S
|
12
|
$
|
11.46
|
OTC
|
|||||||
04/30/2014
|
B
|
11
|
$
|
11.6596
|
OTC
|
|||||||
04/30/2014
|
B
|
12
|
$
|
11.6997
|
OTC
|
|||||||
04/30/2014
|
S
|
11
|
$
|
11.67
|
OTC
|
|||||||
04/15/2015
|
B
|
299
|
$
|
12.6221
|
OTC
|
|||||||
04/15/2015
|
B
|
601
|
$
|
12.6221
|
OTC
|
|||||||
04/17/2015
|
S
|
299
|
$
|
12.6003
|
OTC
|
|||||||
04/17/2015
|
S
|
601
|
$
|
12.6002
|
OTC
|
|||||||
11/24/2015
|
S
|
2,133
|
$
|
12.2262
|
OTC
|
|||||||
11/25/2015
|
B
|
2,133
|
$
|
12.2299
|
OTC
|
|||||||
07/20/2016
|
B
|
1,221
|
$
|
14.08
|
OTC
|
|||||||
07/25/2016
|
S
|
100
|
$
|
14.18
|
BATS Y
|
|||||||
07/25/2016
|
S
|
100
|
$
|
14.18
|
NYSE
|
|||||||
07/25/2016
|
S
|
5
|
$
|
14.18
|
NYSE
|
|||||||
07/25/2016
|
S
|
100
|
$
|
14.18
|
NYSE
|
|||||||
07/26/2016
|
S
|
100
|
$
|
14.15
|
NYSE
|
|||||||
07/26/2016
|
S
|
100
|
$
|
14.15
|
NYSE
|
|||||||
07/26/2016
|
S
|
100
|
$
|
14.15
|
OTC
|
|||||||
07/26/2016
|
S
|
100
|
$
|
14.15
|
NYSE
|
|||||||
07/26/2016
|
S
|
93
|
$
|
14.13
|
NYSE
|
|||||||
07/26/2016
|
S
|
7
|
$
|
14.13
|
NYSE
|
|||||||
07/26/2016
|
S
|
100
|
$
|
14.13
|
BATS X
|
|||||||
07/26/2016
|
S
|
316
|
$
|
14.13
|
BATS X
|
|||||||
09/16/2016
|
S
|
38
|
$
|
13.9101
|
OTC
|
|||||||
10/06/2016
|
B
|
38
|
$
|
14.0599
|
OTC
|
|||||||
10/11/2016
|
S
|
2,200
|
$
|
13.9567
|
OTC
|
|||||||
10/12/2016
|
B
|
131
|
$
|
13.97
|
OTC
|
|||||||
10/12/2016
|
B
|
131
|
$
|
13.97
|
OTC
|
|||||||
10/12/2016
|
B
|
1,471
|
$
|
13.97
|
OTC
|
|||||||
10/12/2016
|
B
|
131
|
$
|
13.97
|
OTC
|
|||||||
10/12/2016
|
B
|
336
|
$
|
13.97
|
OTC
|
|||||||
12/07/2017
|
S
|
570
|
$
|
13.2633
|
OTC
|
|||||||
12/07/2017
|
B
|
570
|
$
|
13.2893
|
OTC
|
|||||||
10/04/2018
|
B
|
300
|
$
|
12.02
|
OTC
|
|||||||
10/31/2018
|
S
|
76
|
$
|
11.82
|
OTC
|
|||||||
10/31/2018
|
S
|
89
|
$
|
11.82
|
OTC
|
|||||||
10/31/2018
|
S
|
46
|
$
|
11.82
|
OTC
|
|||||||
10/31/2018
|
S
|
89
|
$
|
11.82
|
OTC
|
|||||||
06/05/2019
|
S
|
860
|
$
|
13.4701
|
OTC
|
|||||||
06/06/2019
|
B
|
860
|
$
|
13.5178
|
OTC
|
|||||||
03/05/2020
|
B
|
1,394
|
$
|
14.697
|
OTC
|
|||||||
03/05/2020
|
S
|
400
|
$
|
14.68
|
OTC
|
|||||||
03/05/2020
|
S
|
100
|
$
|
14.6795
|
OTC
|
|||||||
03/05/2020
|
S
|
794
|
$
|
14.6795
|
OTC
|
|||||||
03/05/2020
|
S
|
100
|
$
|
14.68
|
OTC
|
|||||||
05/04/2020
|
B
|
2
|
$
|
12.23
|
OTC
|
|||||||
05/05/2020
|
S
|
2
|
$
|
12.28
|
OTC
|
|||||||
06/24/2020
|
B
|
30
|
$
|
13.39
|
OTC
|
|||||||
06/24/2020
|
S
|
14
|
$
|
13.18
|
NASDAQ
|
|||||||
06/24/2020
|
S
|
1
|
$
|
13.2
|
ARCA
|
|||||||
06/24/2020
|
S
|
15
|
$
|
13.16
|
NYSE
|
|||||||
09/29/2020
|
S
|
36
|
$
|
13.45
|
NYSE
|
|||||||
09/29/2020
|
S
|
14
|
$
|
13.4
|
BATS X
|
|||||||
09/29/2020
|
S
|
5
|
$
|
13.42
|
ARCA
|
|||||||
09/29/2020
|
S
|
5
|
$
|
13.42
|
ARCA
|
|||||||
09/29/2020
|
S
|
5
|
$
|
13.42
|
ARCA
|
|||||||
09/29/2020
|
S
|
7
|
$
|
13.42
|
ARCA
|
|||||||
09/29/2020
|
S
|
14
|
$
|
13.45
|
ARCA
|
|||||||
09/29/2020
|
S
|
7
|
$
|
13.45
|
NYSE
|
|||||||
09/29/2020
|
S
|
7
|
$
|
13.45
|
NYSE
|
|||||||
09/29/2020
|
S
|
7
|
$
|
13.47
|
NYSE
|
|||||||
09/29/2020
|
S
|
7
|
$
|
13.48
|
NYSE
|
|||||||
09/30/2020
|
B
|
93
|
$
|
13.45
|
NYSE
|
|||||||
09/30/2020
|
B
|
93
|
$
|
13.45
|
NYSE
|
|||||||
10/06/2020
|
S
|
72
|
$
|
13.61
|
NYSE
|